Zogenix Announces First Patient Dosed in Relday Multi-Dose Clinical Study
March 26, 2015 at 09:04 AM EDT
Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous ...